Antibiotic Resistance

Day Zero shares AI-based approach to antimicrobial susceptibility testing

By LabPulse.com staff writers

A Day Zero Diagnostics research team has unveiled a new approach to antimicrobial susceptibility testing using artificial intelligence (AI) to guide analysis.

June 14, 2024

Sysmex POC urine test wins $10.2M prize

By LabPulse.com staff writers

Product offers potential to end the "just in case" prescribing that is currently prevalent and which promotes the development of antibiotic resistance.

June 13, 2024

Harvard team develops compound to combat drug-resistant bacteria

By Matt Limb

Harvard University researchers say they have created an antibiotic that can overcome many drug-resistant infections.

March 13, 2024

U.K. researchers use deep learning to develop rapid antimicrobial resistance test

By Matt Limb

Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.

December 1, 2023

Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections

By Nick Paul Taylor

Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.

September 28, 2023

Magnolia Medical Technologies publishes survey report on hospitalization risks

By LabPulse.com staff writers

The greatest concern about hospitalization among the 1,002 adults in the U.S. surveyed was the high cost, which outpaced concerns about antimicrobial-resistant bacterial infections, sepsis, hospital-acquired infections, and other risks.

July 26, 2023

Hospitals advised to rethink antibiotic use under new MRSA prevention guidance

By Nick Paul Taylor

The document, which will be published in the journal Infection Control & Hospital Epidemiology, represents the latest thinking on the prevention of methicillin-resistant Staphylococcus aureus (MRSA).

June 28, 2023

Studies show Pathnostics UTI test required fewer resources, reduced costs compared to standard testing

By LabPulse.com staff writers

In the study, the average one-year costs related to UTIs were $501.85 lower for patients receiving treatment based on the Guidance test than for those receiving treatment based on the traditional culture test.

June 20, 2023

Seegene, Werfen partnering to develop syndromic qPCR assays

By LabPulse.com staff writers

The partnership, executed through Seegene's OneSystem initiative, would lead to the joint development of syndromic qPCR assays suitable for the Spanish and Portuguese healthcare systems.

June 14, 2023

Sorrento Therapeutics awarded $4.6M to develop emerging disease diagnostic platform

By LabPulse.com staff writers

Under a U.S. government contract, the firm will aim to develop a platform for the rapid and sensitive detection of proteins and other biomolecules.

June 13, 2023

Metagenomics study finds antibiotic resistance genes are widespread among bacteria

By Elissa Wolfson

Bacteria everywhere carry previously unknown genes that make them resistant to antibiotics, potentially aggravating the problem of untreatable bacterial infections.

June 6, 2023

Asep Medical Holdings aims for Nasdaq listing

By LabPulse.com staff writers

Sepset Biosciences, an Asep Medical business, is preparing for clinical studies aimed at the commercialization of a diagnostic test. The test leverages gene expression to predict the development of severe sepsis.

May 31, 2023

Page 1 of 4

Next Page